This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Cerebral folate deficiency (CFD) has been defined as any neuropsychiatric condition associated with isolated lowering of 5-methyltetrahydrofolate (5-MTHF) levels in CSF and normal systemic folate metabolism.1
CFD has been detected in the infantile-onset CFD syndrome (mediated by serum folate receptor [FR] autoantibodies of the blocking type1) and Aicardi-Goutières and Rett syndromes. In Kearns-Sayre syndrome (KSS), systemic folate deficiency or low CSF 5-MTHF have long been recognized.2,3 Because active transport of 5-MTHF across the choroid plexus epithelial cells is mediated by ATP-dependent processes, we conducted a study to determine CSF 5-MTHF in a series of patients with mitochondrial disorders.
Methods.
Twenty-eight patients with different mitochondrial disorders and fulfilling the previously defined diagnostic criteria4 were recruited from the Hospital Sant Joan de Déu, Barcelona, Spain (21 patients), the University Clinic Aachen, Germany (5 patients), and Hospital 12 de Octubre, Madrid, Spain (2 patients). Diagnosis included KSS (5 patients), neuropathy, ataxia, and retinitis pigmentosa (1 patient), mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke (1 patient), and various clinically heterogeneous respiratory chain enzyme deficiencies (RCD) (21 patients). Brain MRI was performed for each patient. Serum folate and CSF 5-MTHF, glucose, protein, and cells were determined as per established protocol.5 CSF 5-MTHF …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.